Pulmonary Fibrosis Symptoms, Diagnosis, Prognosis and Treatment

September 21, 2017September 20, 2017
IPF and Emotional Outbursts: Why Are They Happening?
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
This is another column in which I hope others living with idiopathic pulmonary fibrosis (IPF) will have some helpful ... Read more
September 21, 2017September 21, 2017
PMD Healthcare Among Those Marking PF Awareness Month with New Tools for Patients
News
PMD Healthcare is among the companies and groups marking Pulmonary Fibrosis Month, and supporting efforts to raise awareness of pulmonary fibrosis (PF) and improve ... Read more
September 20, 2017September 20, 2017
Boehringer Ingelheim Marks IPF Week with App That Helps Doctors Recognize Diseased Lungs’ Sounds
News
Boehringer Ingelheim has joined idiopathic pulmonary fibrosis experts and patient advocacy groups to raise awareness of the early signs ... Read more
September 19, 2017September 18, 2017
Handling PF on My Own
Columns, Just Breathe...Compassionate Help for the PF Journey
I have a new appreciation for PF patients who live on their own or don’t have much help at ... Read more
September 19, 2017September 19, 2017
Phase 2 Results Demonstrate Potential of FibroGen’s Pamrevlumab to Treat IPF
News
The latest Phase 2 trial results of the investigative therapy Pamrevlumab in patients with idiopathic pulmonary fibrosis (IPF) further demonstrated ... Read more
September 18, 2017September 14, 2017
When Illness Dictates Significant Lifestyle Changes
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
It’s no secret that when you are diagnosed with a chronic illness, your life will inevitably change in numerous ... Read more
September 18, 2017September 18, 2017
Study Supports Inhaled Version of miRagen’s MRG-201 as Lung Fibrosis Therapy
News
An inhaled version of miRagen Therapeutics‘ potential fibrosis therapy MRG-201 rendered genes involved in scarring nearly inactive in a rat ... Read more
September 15, 2017September 15, 2017
2 Distinct Groups of Lung Cells Seen to Play ‘Good’ and ‘Bad’ Roles in Diseases Like IPF
News
Scientists at the University of Pennsylvania identified two populations of lung mesenchymal cells that may play a distinct role such ... Read more
September 14, 2017September 13, 2017
Supplemental Oxygen and the Life of a Young Adult
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
Given the stage of life I am in, many people are curious to know what type of work I ... Read more
September 13, 2017September 13, 2017
Synairgen and Pharmaxis Preparing Phase 1 Trial of Potential Fibrosis Therapy
News
Synairgen and Pharmaxis are preparing a Phase 1 clinical trial of PXS-5382A for pulmonary fibrosis and other tissue-scarring disorders. Positive results ... Read more
September 12, 2017September 12, 2017
Ofev-Esbriet Combo Is as Safe as Individual Components as a Pulmonary Fibrosis Therapy, Trial Indicates
Esbriet, News
A combination of Ofev (nintedanib) and Esbriet (pirfenidone) is as safe a therapy for idiopathic pulmonary fibrosis as the ... Read more
September 11, 2017September 8, 2017
I Don’t Always Have an Answer for ‘What’s Wrong?’
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
I have experienced a whirlwind of emotions, good and bad, since being diagnosed with IPF. Sometimes I feel these ... Read more

September 21, 2017September 20, 2017

IPF and Emotional Outbursts: Why Are They Happening?

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

This is another column in which I hope others living with idiopathic pulmonary fibrosis (IPF) will have some helpful tips for me. I don’t know if it is my ... Read more

September 21, 2017September 21, 2017

PMD Healthcare Among Those Marking PF Awareness Month with New Tools for Patients

News

PMD Healthcare is among the companies and groups marking Pulmonary Fibrosis Month, and supporting efforts to raise awareness of pulmonary fibrosis (PF) and improve the care of people with this disease. PF Month, which ... Read more

September 20, 2017September 20, 2017

Boehringer Ingelheim Marks IPF Week with App That Helps Doctors Recognize Diseased Lungs’ Sounds

News

Boehringer Ingelheim has joined idiopathic pulmonary fibrosis experts and patient advocacy groups to raise awareness of the early signs and symptoms of the disease. To help mark IPF World ... Read more

September 19, 2017September 18, 2017

Handling PF on My Own

Columns, Just Breathe...Compassionate Help for the PF Journey

I have a new appreciation for PF patients who live on their own or don’t have much help at home. I also feel gratitude for my husband, who helps ... Read more

September 19, 2017September 19, 2017

Phase 2 Results Demonstrate Potential of FibroGen’s Pamrevlumab to Treat IPF

News

The latest Phase 2 trial results of the investigative therapy Pamrevlumab in patients with idiopathic pulmonary fibrosis (IPF) further demonstrated the drug’s therapeutic potential to reduce fibrosis progression and ameliorate ... Read more

September 18, 2017September 14, 2017

When Illness Dictates Significant Lifestyle Changes

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

It’s no secret that when you are diagnosed with a chronic illness, your life will inevitably change in numerous ways. Lung diseases, such as idiopathic pulmonary fibrosis (IPF), are ... Read more

September 18, 2017September 18, 2017

Study Supports Inhaled Version of miRagen’s MRG-201 as Lung Fibrosis Therapy

News

An inhaled version of miRagen Therapeutics‘ potential fibrosis therapy MRG-201 rendered genes involved in scarring nearly inactive in a rat model of lung fibrosis, the company reported. The preclinical-trial study also ... Read more

September 15, 2017September 15, 2017

2 Distinct Groups of Lung Cells Seen to Play ‘Good’ and ‘Bad’ Roles in Diseases Like IPF

News

Scientists at the University of Pennsylvania identified two populations of lung mesenchymal cells that may play a distinct role such in diseases as pulmonary fibrosis — one that seems to ... Read more

September 14, 2017September 13, 2017

Supplemental Oxygen and the Life of a Young Adult

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

Given the stage of life I am in, many people are curious to know what type of work I do for a living. This curiosity often comes naturally to ... Read more

September 13, 2017September 13, 2017

Synairgen and Pharmaxis Preparing Phase 1 Trial of Potential Fibrosis Therapy

News

Synairgen and Pharmaxis are preparing a Phase 1 clinical trial of PXS-5382A for pulmonary fibrosis and other tissue-scarring disorders. Positive results of preclinical-trial studies on the therapy’s pharmacology — the way ... Read more

September 12, 2017September 12, 2017

Ofev-Esbriet Combo Is as Safe as Individual Components as a Pulmonary Fibrosis Therapy, Trial Indicates

Esbriet, News

A combination of Ofev (nintedanib) and Esbriet (pirfenidone) is as safe a therapy for idiopathic pulmonary fibrosis as the individual components alone, a Phase 4 clinical trial indicates. Preliminary trial findings ... Read more

September 11, 2017September 8, 2017

I Don’t Always Have an Answer for ‘What’s Wrong?’

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

I have experienced a whirlwind of emotions, good and bad, since being diagnosed with IPF. Sometimes I feel these emotions randomly, and other times they are attributed to how ... Read more